MedTrace Logo

Analysis of Impact on Nasal Obstruction by Commercially Available Internal Nasal Stents

NCT00683254 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-05-11

No results posted yet for this study

Summary

Commercially-available internal nasal stents placed inside the nostril should produce decreased nasal obstruction detectable subjectively (volunteers will fill out a survey) and objectively (degree of obstruction will be measured with a rhinomanometer which measure resistant of airflow while breathing through nose).

Conditions

  • Nasal Obstruction

Sponsors & Collaborators

  • Sanostec Corp.

    collaborator INDUSTRY

  • Bethany L. Jones

    lead OTHER

Principal Investigators

  • Bethany L Jones, MD · University of Iowa Department of Otolaryngology

  • Grant Hamilton, MD · University of Iowa Department of Otolaryngology

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00683254 on ClinicalTrials.gov